British footwear brand Dr Martens has reaffirmed its financial outlook for the 2027 fiscal year, saying demand from wholesale customers in the United States, its largest market, remains
encouraging despite broader economic uncertainty.
The company said trading since the start of its financial year in April had been in line with expectations, providing reassurance after a difficult period marked by weaker consumer spending in several regions.
Dr Martens also reported solid performance in Japan and South Korea, while European markets continued to meet expectations despite what it described as a challenging environment for consumers.
Earlier this year, the company said revenue across Europe, the Middle East and Africa had declined, with consumer confidence affected by the economic consequences of the conflict involving Iran.
Analysts surveyed by the company expect Dr Martens to report adjusted pre-tax profit of around £68m ($91m) for the 2027 financial year.
Shares in the footwear maker rose by as much as 3.8% in early London trading before giving up those gains to trade broadly unchanged later in the morning. Photo by Zuckini-Man, Wikimedia commons.
